A kind of multifunctional perfluoropentane (PFP) and ultrasmall Cu2−xS nanodots (u-Cu2−xS NDs) co-incorporated liposome (PFP@ u-Cu2 −xS NDs@liposome) nanocomposite has been facilely and successfully synthesized for enhanced ultrasound/infrared thermal/ photoacoustic multimodal imaging and photothermal therapy upon near infrared (NIR) laser irradiation. Such a liposome-based nanocomposite possesses a number of advantages, such as high dispersity and stability, excellent biocompatibility, small particle size (<100 nm), well-defined core/shell structure, strong NIR absorption and photo-triggered vaporization of PFP, etc. The detailed in vitro investigations demonstrate that the as-synthesized PFP@ u-Cu2−xS NDs@ liposome nanocomposite is capable of enhancing the contrasts of ultrasound/infrared thermal/photoacoustic multimodal imaging, and substantially improving the photothermal therapeutic efficacy. This novel liposome-based theranostic nanoplatform shows great potentials in the future cancer diagnosis and therapy.
its high imaging speed, sensitivity and convenience, but it suffers from relatively low imaging resolution. Recently, the newly developed photoacoustic imaging [25] [26] [27] [28] is emerging as a complementary imaging modality, which combines the high contrast of optical imaging and the high spatial resolution of ultrasound imaging. Therefore, the combination of ultrasound/infrared theramal/photoacoustic imaging techniques will bring unexpected potentials in offering more comprehensive and accurate information with the complementary features of these techniques. In addition, the ingenious strategy of the multimodal imaging-guided PTT will be more powerful and efficient in PTT pre-guidance, intra-monitoring and post-evaluation. Therefore, the exploration of such multifunctional theranostic na noplatforms, which combine both diagnostic and therapeutic functions to allow simultaneous multimodal imaging and therapy as well as the monitoring of tissue/organ's responses to the treatments, has been becoming a research hotspot in the current biomedicine filed.
The design of liposome-based nanocomposites [29] [30] [31] [32] ] offered a great potential for the fabrication of such multifunctional theranostic nanoplatforms. Perfluorocarbons (PFCs) incorporated liposome [33] [34] [35] [36] has long been being a common contrast agent for the ultrasound imaging by providing contrast enhancement through an acoustic impedance mismatch or resonance. Recently, a laser-induced phase transformation [37, 38] was proposed aiming at providing a safer and more controllable process of vaporization by using less energy than that of high-intensity ultrasound. Upon laser irradiation, a liquid-to-gas phase transformation of PFCs takes place due to the temperature elevation via the conversion of laser energy. The resulting PFCs bubbles are capable of enhancing contrast of ultrasound/ photoacoustic imaging [39, 40] and inducing cavitation for therapy [41] [42] [43] by the bubble formation and explosion. This kind of laser-induced phase transformation can be realized by the combination of PFCs droplets with various photosensitizers, such as indocyanine green (ICG)-loaded perfluorocarbon nanodroplets, gold nanoparticles and perfluorohexane liquid (PFH) co-loaded PLGA [42, 43] .
Herein, we propose a novel single NIR laser induced multifunctional theranostic nanoplatform for ultrasound/ infrared thermal/photoacoustic multimodal imaging and photothermal therapy , based on the rational design and construction of perfluoropropane (PFP) and ultrasmall Cu 2−x S nanodots (u-Cu 2−x S NDs) co-loaded liposome (abbreviated as PFP@u-Cu 2−x S NDs@liposome). This multifunctional PFP@u-Cu 2−x S NDs@liposome can be facilely synthesized via a typical thin film method, and demonstrates a number of excellent properties, including high dispersity and stability in aqueous solution, excellent biocompatibility, small particle size (<100 nm), well-defined core/shell structure, and strong NIR absorption originating from the copper deficient u-Cu 2−x S NDs, which is attributed to the localized surface plasmon resonances [44] [45] [46] . In addition, PFP bubbles can be detected upon NIR laser irradiation. Therefore, the PFP@u-Cu 2−x S NDs@liposome is demonstrated to be capable of providing significant contrast enhancements for ultrasound/infrared thermal/ photoacoustic multimodal imaging, and improving photothermal therapeutic efficacy for killing cancer cells in vitro. This novel NIR laser induced multifunctional theranostic nanoplatform based on PFP@u-Cu 2−x S NDs@liposome nanocomposite will attract extensive interest in future cancer diagnosis and therapy.
RESULTS AND DISCUSSIONS
The as-synthesized PFP and u-Cu 2−x S NDs co-incorporated liposome (PFP@u-Cu 2−x S NDs@liposome) for ultrasound/ infrared thermal/photoacoustic multimodal imaging and photothermal therapy is illustrated in Scheme 1. The novel PFP@u-Cu 2−x S NDs@liposome was facilely and successfully synthesized by incorporating hydrophobic fluorocarbon compound PFP of low boiling point (29C) in the core and u-Cu 2−x S NDs in the shell.
Blank liposome was prepared via a typical thin film method [47] . The representative transmission electron microscopy (TEM) image (Fig. 1a) of the as-synthesized blank liposome shows that the liposome is quasi-spherical with a multilamellar structure and a mean diameter of 100 nm. This morphology offers high potential for the incorporation of PFP and u-Cu 2−x S NDs with controllable bubbles release upon NIR laser irradiation. Moreover, the size of the liposome can be tailored in the synthetic process, ranging from several micrometers to dozens of nanometers, as shown in Fig. S1 . The u-Cu 2−x S NDs with a diameter of 2 nm (Fig. 1b) was synthesized as previously reported [48] . (Fig. S2 ) confirm the successful incorporation of u-Cu 2−x S NDs. The hydrodynamic diameter of the PFP@u-Cu 2−x S NDs@lipo-some was measured to be around 130 nm (Fig. S3a ) and the Zeta potential was determined to be about −13 mV (Fig.  S3b ). In addition, there was no change in the hydrodynamic diameter and Zeta potential after being kept at 4C for 3 and 7 days, demonstrating the high stability of this multifunctional liposome nanoplatform. Moreover, it is worth noting that the as-synthesized PFP@u-Cu 2−x S NDs@ liposome shows a broad and strong absorption from 800 to 1400 nm (Fig. 1e) , with a peak locating in the second NIR window (1000-1350 nm). Additionally, the absorption intensity is linearly enhanced with increasing Cu 2+ concentration ( Fig. 1f) , which is determined by inductively coupled plasma atomic emission spectroscopy (ICP-AES).
In order to distinctly demonstrate the successful in- 
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corporation of PFP in PFP@u-Cu 2−x S NDs@liposome, the bubble generation assays in both hot water (60C) and by exposure to NIR laser irradiation were carried out. As shown in Figs 2a and b, the reference u-Cu 2−x S NDs@li-posome sample without PFP shows no bubble generation both before and after being immersed in hot water. However, a great amount of smaller-sized phase-changed PFP micro-bubbles emerge in PFP@u-Cu 2−x S NDs@liposome dispersion after either being immersed in hot water (Figs 2c and d) or exposed to NIR laser irradiation (Figs 2e and f), which undoubtedly confirms that both PFP and u-Cu 2−x S NDs have been successfully incorporated into the liposome and great numbers of vaporized PFP nanoemulsions have been converted into gas bubbles. These small bubbles will further swell and merge into larger microbubbles, which is beneficial for enhanced ultrasound/photoacoustic imaging under NIR laser irradiation. Encouraged by the strong NIR absorption of PFP@u-Cu 2−x S NDs@liposome and sustained generation of PFP gas bubbles under NIR laser irradiation, we further investigated its contrast enhancement capability for ultrasound/ infrared thermal/photoacoustic multimodal imaging and photothermal effect in vitro. Two mililiter of PFP@lipo-some as a control and PFP@u-Cu 2−x S NDs@liposome dispersions (Cu 2+ concentration: 50 ppm) were wrapped up by a plastic tube and immersed into the degassed water tank for the following ultrasound imaging under NIR laser irradiation. The reference PFP@liposome dispersion shows no ultrasound imaging contrast enhancement after NIR laser irradiation (Figs 3a and b) . Comparatively, a remarkable contrast enhancement (Figs 3c and d) is observed in plastic tube containing the PFP@u-Cu 2−x S NDs@liposome dispersion under exposure to NIR laser irradiation for 5 min (980 nm, power density: 1.41 W cm −2 ), which is attributed to the generation of large amount of PFP gas bubbles originated from the phase transformation of PFP. To further study the contrast enhancement capability of the PFP@u-Cu 2−x S NDs@liposome for infrared thermal imaging, infrared thermal images of reference water droplet and aqueous droplets containing the PFP@u-Cu 2−x S NDs@ liposome (Cu 2+ concentration, C1: 12.5 ppm, C2: 50 ppm) at different time intervals were recorded during NIR laser irradiation for comparison. As shown in Figs 3e-h, water droplet shows no contrast enhancement and negligible temperature rise. In contrast, significant contrast enhanced infrared thermal images and temperature elevation are detected in the aqueous droplets containing the PFP@u-Cu 2− x S NDs@liposome under the same experimental conditions, indicating that this multifunctioal PFP@u-Cu 2−x S NDs@liposome is capable of enhancing the contrast of infrared thermal imaging. Furthermore, its potential of acting as a candidate contrast agent for photoacoustic imaging was also evaluated in vitro. Linear concentration-enhanced photoacoustic signals and images are obtained (Fig. 3i) . In all, the PFP@u-Cu 2−x S NDs@liposome is demonstrated to be capable of substantially enhancing the contrasts of ultrasound/infrared thermal/photoacoustic multimodal imaging.
Moreover, the strong NIR absorption of PFP@u-Cu 2−x S NDs@liposome motivated us to investigate its photothermal effect. The temperature elevations of the aqueous dispersions containing PFP@u-Cu 2−x S NDs@liposome at different Cu 2+ concentrations and under NIR laser irradiation at different power densities were measured. Pure water as a control demonstrated a temperature rise of 5C under NIR laser irradiation with a power density of 1.41 W cm −2 . Comparatively, the aqueous dispersions containing PFP@u-Cu 2−x S NDs@liposome showed a temperature increase of 10-20C in 5 min under the same experimental condition (Fig. 3j) , and the heating rate increased with the increasing power density (Fig. S4) . Thus, it is believed that the PFP@u-Cu 2−x S NDs@liposome can efficiently and rapidly convert the 980 nm laser energy into hyperthermia, resulting from the strong absorption of Cu 2−x S NDs in NIR region. All these results demonstrate that this novel multifunctional PFP@u-Cu 2−x S NDs@liposome shows great potential in serving as an excellent contrast agent for ultrasound/infrared thermal/photoacoustic multimodal 
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imaging and a highly efficient photothermal agent for photothermal therapy.
Furthermore, the cytotoxicity of the nanocomposite was evaluated by a standard 3-[4, 5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) assay on HeLa cells. As expected, the PFP@u-Cu 2−x S NDs@liposome appears to be basically non-toxic. The cell viabilities are all above 90% even at a high Cu 2+ concentration up to 100 ppm, as shown in Fig. S5 (the black histogram) . Afterwards, the photothermal effect on HeLa cells was investigated. As demonstrated in Fig. S5 (the red histogram) , the PFP@u-Cu 2−x S NDs@liposome exhibits a concentration-dependent cell death feature under NIR laser irradiation. In addition, the cell death was visualized by trypan blue staining in optical microscope. The control groups including HeLa cells without treatment, treated with the PFP@u-Cu 2−x S NDs@lipo-some alone and NIR laser irradiation alone show no changes after trypan blue staining (Figs 4a-c) . However, the cells treated with PFP@u-Cu 2−x S NDs@liposome and NIR laser irradiation are stained in blue, indicating that severe cell death (Fig. 4d) took place. Moreover, the cellular uptakes of the PFP@u-Cu 2−x S NDs@liposome at varied duration were studied prior to confirming the cell death by confocal laser scanning microscopy (CLSM). It can be clearly found that most of the PFP@u-Cu 2−x S NDs@liposome particles are in the cytoplasm of HeLa cells in 1 h (Fig. S6a ) and 4 h (Fig. S6b) of co-incubation, demonstrating that the PFP@u-Cu 2−x S NDs@liposome can be rapidly endocytosed by HeLa cells. The serve cell death was further verified by co-staining with calcein-AM and prodium iodide (PI) by CLSM. Similarly, the control cell groups mentioned above are stained in green after calcein-AM and PI co-staining, corresponding to live cells (Figs 4e-g ). In contrast, the cells treated with the PFP@u-Cu 2-x S NDs@liposome and NIR laser irradiation are stained in red, assigning to dead cells (Fig. 4h) . These data are consistent with the results of MTT 
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assay and optical microscopic imaging. Therefore, it is believed that the PFP@u-Cu 2−x S NDs@liposome is a highly effective photothermal agent to kill cancer cells in vitro, which is mainly attributed to the strong NIR absorption property, and therefore shows great potential in photothermal therapy in vivo.
CONCLUSION
In summary, a novel NIR laser induced multifunctional theranostic nanoplatform based on PFP@u-Cu 2−x S NDs@lipo-some has been facilely and successfully fabri cated. This kind of PFP@u-Cu 2−x S NDs@liposome nanocomposite demonstrates high dispersity and stability in aqueous solution, excellent biocompatibility; small particle size (<100 nm) and well-defined core/shell structure with PFP in the core and u-Cu 2−x S NDs in the shell. Specially, this nanocomposite exhibits strong absorption in the NIR region originating from unusual defect structure of u-Cu 2−x S NDs. Therefore, this nanocomposite is capable of converting laser energy to hyperthermia to induce the phase transformation of PFP, resulting in sustained generation of gas bubbles. Under the same NIR laser irradiation, the PFP@u-Cu 2−x S NDs@ liposome is capable of generating significant contrast enhancement for ultrasound/infrared thermal/photoacoustic multimodal imaging and serving as an efficient photothermal agent for killing cancer cells. Thus, the as-synthesized PFP@u-Cu 2−x S NDs@liposome will be a promising agent in multimodal imaging-guided photothermal therapy, which, as we believe, will also provide an ingenious strategy for the intensive exploration of liposome-based multifunctional nanomaterials in future in vivo cancer diagnosis and therapy. ) together. All the scale bars in (a-h) are 50 m.
